ArticleCureus2024

Real-World Clinical Profile and Safety of Nintedanib in Systemic Sclerosis-Associated Interstitial Lung Disease: A Subgroup Analysis of Interstitial Lung Disease Data From an Interstitial Lung Disease (ILD) Specialty Clinic in India.

Ajoy K Behera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.